Kyntra Bio (KYNB) Raw Materials (2018 - 2024)
Kyntra Bio (KYNB) posted Raw Materials of $948000.0 for Q3 2024, down 6.88% sequentially from $1.0 million in Q2 2024, and down 19.59% YoY from $1.2 million in Q4 2023.
Kyntra Bio (KYNB) Raw Materials (2018 - 2024) Analysis & Trends
Kyntra Bio has reported Raw Materials for 7 years, with the latest figure at $948000.0 in Q3 2024.
- Quarterly Raw Materials fell 19.59% year-over-year to $948000.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $948000.0 (down 19.59% YoY) and the FY2023 annual result came in at $787000.0, down 36.58% from the prior year.
- Raw Materials eased to $948000.0 in Q3 2024 per KYNB's latest filing, from $1.0 million in the prior quarter.
- Over five years, Raw Materials peaked at $3.3 million in Q1 2021 and troughed at $327000.0 in Q2 2020.
- A 5-year average of $1.2 million and a median of $1.2 million in 2023 frame the typical range for Raw Materials.
- The sharpest annual moves came in 2020 and 2021: Raw Materials plunged 58.97% in 2020, then surged 620.7% in 2021.
- Over 5 years, Raw Materials stood at $2.3 million in 2020, then sank by 40.82% to $1.4 million in 2021, then slipped by 8.95% to $1.2 million in 2022, then tumbled by 36.58% to $787000.0 in 2023, then advanced by 20.46% to $948000.0 in 2024.
- According to Business Quant data, Raw Materials over the past three periods registered $948000.0, $1.0 million, and $1.1 million for Q3 2024, Q2 2024, and Q1 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Kyntra Bio | 29.83 Mn | 29.83 Mn | 1.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 948,000.00 |
| Jun 30, 2024 | 1.02 Mn |
| Mar 31, 2024 | 1.08 Mn |
| Dec 31, 2023 | 787,000.00 |
| Sep 30, 2023 | 1.18 Mn |
| Jun 30, 2023 | 1.08 Mn |
| Mar 31, 2023 | 1.23 Mn |
| Dec 31, 2022 | 1.24 Mn |
| Sep 30, 2022 | 1.23 Mn |
| Jun 30, 2022 | 1.22 Mn |
| Mar 31, 2022 | 1.36 Mn |
| Dec 31, 2021 | 1.36 Mn |
| Sep 30, 2021 | 820,000.00 |
| Jun 30, 2021 | 1.19 Mn |
| Mar 31, 2021 | 3.31 Mn |
| Dec 31, 2020 | 2.30 Mn |
| Sep 30, 2020 | 1.15 Mn |
| Jun 30, 2020 | 327,000.00 |
| Mar 31, 2020 | 459,000.00 |
| Dec 31, 2019 | 325,000.00 |